It is expected that the death rate from diabetes will top 50% in the next ten years, which will make it a leading cause of death worldwide.
Keep Reading →
June 28 - News
Famed investor Warren Buffett once called the high cost of health care a "tapeworm eating at our economic body." While he might be disgusted by the costs, it hasn't stopped ...
Keep Reading →
June 27 - Hedge Fund Analysis
Biotech companies sometimes get lucky, launching a drug into a new indication where there's no competition, but more often than not the biotech companies have to battle it out...
Keep Reading →
June 27 - News
SAC Capital Advisors, the hedge fund managed by billionaire Steve Cohen and his team, has filed a 13G with the SEC to report that it owns 7.6 million shares of Zoetis Inc (NYSE...
Keep Reading →
June 25 - Hedge Funds
Blame it on a "case of the Mondays" or perhaps a rough night out on the town, but for many of us getting a good night's rest isn't nearly as simple as it sounds.
Keep Reading →
June 25 - News
Shares of biotech Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) have soared over 160% in the past year.
Keep Reading →
June 20 - News
Technological advances have allowed for people to have more longevity. Drug companies research and develop medicines to prevent, control and cure diseases.
Keep Reading →
June 19 - News
For lack of a better phrase, those who have type 1 diabetes -- a form of diabetes whereby the person's own autoimmune system attacks or attempts to destroy cells in the pancreas...
Keep Reading →
June 18 - News
About a third of American adults have high LDL cholesterol -- that's the bad kind -- but less than half of adults with high LDL seek treatment, according to the Centers for Disease...
Keep Reading →
June 18 - News
After a year-long dream run, Biogen Idec Inc. (NASDAQ:BIIB) lost 5.25% in the week ended Friday, June 7.
Keep Reading →
June 17 - News
"Made in China." It's a slogan emblematic of many things – of cheap labor, of the loss of U.S.
Keep Reading →
June 17 - News
It's understandably very tempting for people with inside information to trade biotech stocks.
Keep Reading →
June 17 - News
Generic-drug makers are always on the hunt for the next branded drug to take down.
Keep Reading →
June 13 - News
Nearly every big pharma player has been hit with patent expirations that have hit hard on sales lately, and Merck & Co., Inc. (NYSE:MRK) is no exception. Merck & Co., Inc.
Keep Reading →
June 12 - News
"Making every patient count" is a catchy phrase that is perhaps most meaningful for biotech companies like NPS Pharmaceuticals, Inc.
Keep Reading →
June 4 - News
Biotechnology stocks offer investors some of the highest potential for returns of any industry.
Keep Reading →
June 4 - News
If you'd owned these three biotech companies at the beginning of the year, you're sitting on around a triple compared to a relatively smaller-but-still-impressive 34% increase...
Keep Reading →
June 3 - News
For a long time, Africa’s traditional enemy with regard to diseases have been communicable diseases like HIV and Malaria. Now, however, this trend is changing.
Keep Reading →
June 3 - News
Pfizer Inc. (NYSE:PFE) recently announced plans to sell its remaining 80% stake in animal-health company Zoetis Inc (NYSE:ZTS) after about four months on the public market.
Keep Reading →
May 31 - News
As we've learned over the past few years, getting a drug approved by the Food and Drug Administration is just half the battle in the biotech sector.
Keep Reading →
May 31 - News
The field of synthetic biology is still in its infancy, with many of the most promising companies residing outside of public markets, but make no mistake: The bioeconomy is on...
Keep Reading →
May 31 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
May 29 - News
A recent review published online in the journal, The Lancet, found nearly a quarter of all adults are unhappy with their sleep patterns.
Keep Reading →
May 29 - News
Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Keep Reading →
May 22 - News
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
May 20 - News
Shares of Aegerion Pharmaceuticals, Inc.
Keep Reading →
May 20 - News
Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable.
Keep Reading →
May 20 - News
MannKind Corporation (NASDAQ:MNKD) took one giant leap over the past few days.
Keep Reading →
May 19 - News
Avastin -- which the Food and Drug Administration has approved to treat metastatic colorectal cancer (as a first-line and second-line treatment), metastatic HER2-negative breast...
Keep Reading →
May 19 - News
Perennial underdog MannKind Corporation (NASDAQ:MNKD) could be on its countdown to liftoff.
Keep Reading →
May 10 - News
VIVUS, Inc. (NASDAQ:VVUS) has the first part down.
Keep Reading →
May 9 - News
Investments in biotechnology by the average investor tend to deliver hit or miss returns over time.
Keep Reading →
May 8 - News
Wall Street had a great week. The Dow topped 15,000. The S&P 500 also notched a record high. But few stocks blew the doors off like those of these three biotech companies.
Keep Reading →
May 4 - News
It's that time of year. The sounds of sneezing, coughing, and sniffling can be heard across America. Around 40 million people in the U.S.
Keep Reading →
May 4 - News
Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately.
Keep Reading →
May 1 - News
One of the nice things about owning biotech companies is the large number of acquisitions in the sector.
Keep Reading →
April 30 - News
Heart disease kills nearly 600,000 Americans every year, making it the nation's No. 1 cause of death, according to the Centers for Disease Control and Prevention.
Keep Reading →
April 24 - News
Within the next few days, stocks for two orphan drugmakers could either soar or sink. Both Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and Raptor Pharmaceutical Corp.
Keep Reading →
April 24 - News
Tomorrow, Eli Lilly & Co. (NYSE:LLY) will release its latest quarterly results.
Keep Reading →
April 23 - News
A popular drug that crosses a benchmark sale of $1 billion for the manufacturer is called a blockbuster drug.
Keep Reading →
April 18 - News
Two high-flying biotech stocks of late are NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) .
Keep Reading →
April 16 - News
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Keep Reading →
April 9 - News
Roche Holding Ltd. (ADR) (PINK:RHHBY) and ISIS Pharmaceuticals, Inc.
Keep Reading →
April 8 - News
Warren Buffett knows what he likes -- and he gets what he likes.
Keep Reading →
April 7 - News
The immune system doesn't generally attack tumors on its own. Immune cells are designed to attack foreign invaders but leave the human cells alone.
Keep Reading →
March 31 - News
Last November, I examined five experimental drugs that appeared as if they had all of the tools necessary to become life-changing blockbusters from a financial and quality of ...
Keep Reading →
March 28 - News
After a wildly successful IPO that raised over $2 billion, and valued the newly-created company at more than $12 billion, pharmaceutical giant Pfizer Inc.
Keep Reading →
March 28 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 27 - News
Every year, it appears that flu season starts earlier and earlier, and somehow, every year, the virus mutates into its "most virulent form ever." Sometimes it's a wonder we even...
Keep Reading →
March 25 - News
You can't find a hotter topic in health care than obesity.
Keep Reading →
March 20 - News
